Curative Biosciences, Inc.
CBDX
$0.0001
$0.000.00%
| 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | 03/31/2017 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 516.40K | 488.40K | 43.70K | 51.80K | 79.70K |
| Depreciation & Amortization | 1.40K | 1.40K | 1.40K | 1.40K | 1.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 518.10K | 490.10K | 45.40K | 53.20K | 81.10K |
| Operating Income | -518.10K | -490.10K | -45.40K | -53.20K | -81.10K |
| Income Before Tax | -518.10K | -490.10K | -45.40K | -53.20K | -81.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.52 | -0.49 | -0.05 | -0.05 | -0.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -518.10K | -490.10K | -45.40K | -53.20K | -81.10K |
| EBIT | -518.10K | -490.10K | -45.40K | -53.20K | -81.10K |
| EBITDA | -515.50K | -487.30K | -42.60K | -50.40K | -78.30K |
| EPS Basic | -0.03 | -0.03 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | -0.02 | -0.02 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.03 | -0.03 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | -0.02 | -0.02 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 67.11M | 63.24M | 62.86M | 62.83M | 62.68M |
| Average Diluted Shares Outstanding | 67.11M | 63.24M | 62.86M | 62.83M | 62.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
